Onconetix Financials

$0.67

$0.02 (2.85%)

As on 02-Sep-2026 14:33EDT

Market cap

$2 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

0

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.65	0.82	2.52	0.06	--	--
Cost of Revenue	0.13	0.18	1.47	1.19	0.01	0.00
Gross Profit	0.52	0.63	1.06	-1.13	-0.01	0.00
Operating Expenses	8.69	6.98	57.54	34.91	13.48	3.42
Operating Profit (EBIT)	-8.17	-6.34	-56.49	-36.03	-13.48	-3.42
Other Income	--	--	--	--	--	--
Profit before Tax	-10.20	-14.03	-59.74	-37.42	-13.42	-3.42
Provision for Tax	0.00	0.00	-1.05	-0.01	-0.06	0.00
Profit after Tax (Net Income)	-10.20	-14.03	-58.69	-37.41	-13.42	-3.42
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	13.47	15.76	9.61	-5.60	22.39	1.45
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.01	0.02	0.28	68.92	--	--
Current Liabilities	2.94	9.14	18.29	17.19	3.92	1.64
Total Liabilities	19.37	24.93	28.18	87.52	26.31	3.08

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	9.91	18.86	27.23	81.68	0.05	0.01
Current Assets	6.52	6.07	0.95	5.84	26.26	3.07
Total Assets	22.94	24.92	28.18	87.52	26.31	3.08
Total Debt*	0.19	0.05	9.45	9.89	--	--
Net Current Assets	--	-3.07	-17.34	-11.35	22.34	1.44

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-9.68	-10.50	-13.58	-8.68	-2.04
Cash Flow from Investing Activities	--	--	-0.03	-8.65	-0.03	0.00
Cash from Financing Activities	--	14.45	6.74	1.04	32.53	-0.33
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-8.04	-8.04	-4.28	-2,118.81	-67.03	-854.77
Cash EPS ($)	--	--	-4.27	-2,092.41	-66.95	-854.34
Adjusted Book Value ($)	--	--	4.80	346.95	--	1,425.99
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	-2.95	-378.91	-24.33	-552.58
Free Cash Flow per Share ($)	--	--	-2.95	-379.94	-24.43	-553.18

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	--	-80.48	-502.88	-280.52	-112.61
ROE (%)	-69.76	-69.76	-110.60	-2,928.31	-445.73	-112.61
ROA (%)	-37.24	-37.24	-52.84	-101.45	-65.73	-91.31
EBIT Margin (%)	-1,087.26	-1,087.26	-1,628.81	-2,310.85	-62,859.25	--
Net Margin (%)	-1,578.79	-1,578.79	-1,720.98	-2,325.21	-63,986.48	--
Cash Profit Margin (%)	-0.13	-0.13	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-51.33	-51.33	-0.68	42.17	--	--
EBIT Growth (%)	49.74	49.74	77.23	-58.71	-173.85	-292.70
Net Profit Growth (%)	76.92	-74.10	76.09	-56.89	-178.76	-292.70
EPS Growth (%)	99.30	99.30	1.00	-30.61	0.92	-1.85
Book Value Growth (%)	101.89	101.89	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	0.00	0.00	-0.36	0.00	--	--
Price / Book Value	0.19	0.19	0.32	0.00	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.47	-0.47	0.00	-0.15	--	--
Close Price ($)	1.13	1.13	78.00	2,677.50	--	--
High Price ($)	270.00	270.00	4,420.00	563,040.00	--	--
Low Price ($)	0.88	0.88	68.50	1,340.88	--	--
Market Cap ($ Cr)	2.42	2.42	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	0.00	0.98	-1.76	--
Short term debt to equity ratio	0.01	0.01	0.00	0.98	-1.73	--
Current Ratio	2.21	2.21	0.66	0.05	0.34	6.69
Quick Ratio	2.14	2.14	0.65	0.05	0.32	6.69
Interest Coverage	-31.79	-31.79	-17.68	-41.44	-54.72	--

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	0.36	0.36	36.41	3.82	256.10	--
Asset Turnover	0.02	0.02	0.03	0.04	0.00	--
Receivable days	--	--	88.06	17.80	579.69	--
Inventory Days	--	--	214.24	53.22	56.08	20,492.46
Payable days	--	--	5,550.33	1,129.14	1,046.56	56,310.30
Cash Conversion Cycle	--	--	-5,248.04	-1,058.11	-410.79	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.